Chi-Med steps closer to Chinese pharma first with drug filing

LONDON (Reuters) - Hutchison China MediTech, the Shanghai-based drugmaker listed in London, is a step closer to winning approval for a modern drug developed in a Chinese lab with the submission of its cancer medicine fruquintinib to China's drug watchdog. (Source: Reuters: Health)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2rmjIre
via IFTTT